High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$46.1M
$46,119,636
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
EIKN
P
Eikon Therapeutics, Inc.
Column Group IV GP, LP
• 10% Owner
Discretionary BuyΔOwn +50.0%
2026-02-06
$25,871,814MEGA
|
||||||
| EIKN |
Eikon Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +50.0%
|
2026-02-06 | $25,871,814MEGA | P | Form 4 |
|
EIKN
P
Eikon Therapeutics, Inc.
Column Group IV GP, LP
• 10% Owner
Discretionary BuyΔOwn +49.9%
2026-02-06
$892,008
|
||||||
| EIKN |
Eikon Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +49.9%
|
2026-02-06 | $892,008 | P | Form 4 |
|
EIKN
P
Eikon Therapeutics, Inc.
Column Group IV GP, LP
• 10% Owner
Discretionary BuyΔOwn +91.7%
2026-02-06
$11,355,858MEGA
|
||||||
| EIKN |
Eikon Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +91.7%
|
2026-02-06 | $11,355,858MEGA | P | Form 4 |
|
EIKN
P
Eikon Therapeutics, Inc.
FRAZIER KENNETH C
• Director
Discretionary Buy
2026-02-04
$1,999,998Large
|
||||||
| EIKN |
Eikon Therapeutics, Inc.
|
Director
Discretionary Buy
|
2026-02-04 | $1,999,998Large | P | Form 4 |
| EIKN |
Eikon Therapeutics, Inc.
|
Director
Discretionary Buy
|
2026-02-04 | $2,499,984Large | P | Form 4 |
|
EIKN
P
Eikon Therapeutics, Inc.
Lux Venture Partners V, LLC
• 10% Owner
Discretionary Buy
2026-02-04
$2,499,984Large
|
||||||
| EIKN |
Eikon Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2026-02-04 | $2,499,984Large | P | Form 4 |
|
EIKN
P
Eikon Therapeutics, Inc.
Foresite Capital Management IV, LLC
• 10% Owner
Discretionary Buy
2026-02-04
$999,990
|
||||||
| EIKN |
Eikon Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2026-02-04 | $999,990 | P | Form 4 |